# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA664612 | F | Ability to inhibit growth of Dictostelium discoideum. | Dictyostelium discoideum | 16 | organism-based format | Scientific Literature | ||
2. | ALA676676 | F | In vitro growth inhibition against Entamoeba histolytica | Entamoeba histolytica | 102 | organism-based format | Scientific Literature | ||
3. | ALA681824 | F | Inhibitory activity, for stimulation of TNF-alpha release in gamma-delta T cells, using a constrained maximum TNF-alpha release of 2700 pg/mL | Homo sapiens | 61 | cell-based format | Scientific Literature | ||
4. | ALA681825 | F | Inhibitory activity, for stimulation of TNF-alpha release in gamma-delta T cells, using individual observed maximum TNF-alpha release | Homo sapiens | 45 | cell-based format | Scientific Literature | ||
5. | ALA681826 | F | pIC50 value for stimulation of TNF-alpha release in gamma-delta T cells, using a constrained maximum TNF-alpha release of 2700 pg/mL | Homo sapiens | 61 | cell-based format | Scientific Literature | ||
6. | ALA681827 | F | pIC50 value for stimulation of TNF-alpha release in gamma-delta T cells, using individual observed maximum TNF-alpha release | Homo sapiens | 45 | cell-based format | Scientific Literature | ||
7. | ALA681890 | B | Inhibitory activity against farnesyl Pyrophosphate Synthase was determined | Leishmania major | 61 | single protein format | Scientific Literature | ||
8. | ALA681891 | B | Binding affinity towards farnesyl Pyrophosphate Synthase using [14C]- isopentenyl pyrophosphate as radioligand | Leishmania major | 62 | single protein format | Scientific Literature | ||
9. | ALA857167 | B | Inhibitory activity against farnesyl Pyrophosphate Synthase expressed as #NAME? (M) | Leishmania major | 61 | single protein format | Scientific Literature | ||
10. | ALA700364 | T | Toxicity evaluated against human nasopharyngeal carcinoma KB cell line | Homo sapiens | 102 | cell-based format | Scientific Literature | ||
11. | ALA769481 | F | In vitro growth inhibition against Plasmodium falciparum | Plasmodium falciparum | 102 | organism-based format | Scientific Literature | ||
12. | ALA786021 | F | Bone resorption activity in rats. | Rattus norvegicus | 35 | organism-based format | Scientific Literature | ||
13. | ALA835402 | A | Therapeutic index (TI) value as ratio of lethal dose (LD50) to the inhibitory concentration (IC50) | 41 | cell-based format | Scientific Literature | |||
14. | ALA874944 | F | In vitro inhibitory concentration against the growth of Toxoplasma gondii in human foreskin fibroblast monolayer cells (HFF cells) | 60 | cell-based format | Scientific Literature | |||
15. | ALA836410 | F | Lethal dose required to inhibit the growth of human KB (nasopharyngeal carcinoma) cell line | Homo sapiens | 41 | cell-based format | Scientific Literature | ||
16. | ALA910461 | F | Antibacterial activity against Escherichia coli W3110 | Escherichia coli | 117 | organism-based format | Scientific Literature | ||
17. | ALA910462 | F | Antibacterial activity against Escherichia coli pTMV19 | Escherichia coli | 47 | organism-based format | Scientific Literature | ||
18. | ALA910463 | F | Antibacterial activity against Escherichia coli pTMV19 in presence of mevalonate | Escherichia coli | 47 | organism-based format | Scientific Literature | ||
19. | ALA2049638 | B | Inhibition of human recombinant N-terminal-His6 tagged FPPS expressed in Escherichia coli BL21 using [14C]IPP and GPP as substrate incubated for 10 mins prior to substrate addition measured after 10 mins by scintillation counting | Homo sapiens | 14 | assay format | Scientific Literature | ||
20. | ALA2049639 | B | Inhibition of human recombinant N-terminal-His6 tagged FPPS expressed in Escherichia coli BL21 using [3H]IPP and GPP as substrate at 1 uM incubated for 10 mins prior to substrate addition measured after 20 mins by liquid scintillation counting | Homo sapiens | 18 | assay format | Scientific Literature |